Junjia Zhu, Ph.D. - Publications

Affiliations: 
2008 Pennsylvania State University, State College, PA, United States 
Area:
Statistics, Industrial Engineering

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee SY, Walter V, Zhu J, Salzberg AC, Liu DJ, Connor JR. Impact of HFE variants and sex in lung cancer. Plos One. 14: e0226821. PMID 31856248 DOI: 10.1371/Journal.Pone.0226821  0.305
2019 Zhu J, Hussain M, Joshi A, Truica CI, Nesterova D, Collins J, Saunders EFH, Hayes M, Drabick JJ, Joshi M. Effect of creative writing on mood in patients with cancer. Bmj Supportive & Palliative Care. PMID 30824430 DOI: 10.1136/Bmjspcare-2018-001710  0.3
2019 Poulose J, Wheelden M, Mackley HB, Schmeck C, Zhu J, Pameijer C, Neves RI, Schell T, Mallon C, Drabick JJ. Utility of concurrent immunoradiation for locally advanced and/or medically inoperable melanoma and Merkel cell carcinoma. Journal of Clinical Oncology. 37: e21053-e21053. DOI: 10.1200/Jco.2019.37.15_Suppl.E21053  0.31
2019 Pu JJ, Poulose J, Zhu J, Malysz J, Fanburg-Smith J, Bayerl M. Ruxolitinib Maintenance Post Myelofibrosis Allogeneic Stem Cell Transplant Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.404  0.304
2018 Kokolus KM, Zhang Y, Sivik JM, Schmeck C, Zhu J, Repasky EA, Drabick JJ, Schell TD. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology. 7: e1405205. PMID 29399407 DOI: 10.1080/2162402X.2017.1405205  0.304
2017 Lee SY, Zhu J, Salzberg AC, Zhang B, Liu DJ, Muscat JE, Langan ST, Connor JR. Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data. Plos One. 12: e0174778. PMID 28358914 DOI: 10.1371/Journal.Pone.0174778  0.317
2016 Joshi M, Vasekar M, Grivas P, Emamekhoo H, Hsu J, Miller VA, Stephens PJ, Ali SM, Ross JS, Zhu J, Warrick J, Drabick JJ, Holder SL, Kaag M, Li M, et al. Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma. Oncotarget. PMID 27213592 DOI: 10.18632/Oncotarget.9449  0.313
2015 Das A, Kunkel M, Joudeh J, Dicker DT, Scicchitano A, Allen JE, Sarwani N, Yang Z, Kaifi J, Zhu J, Liao J, El-Deiry WS. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation. Cancer Biology & Therapy. 16: 709-13. PMID 25806877 DOI: 10.1080/15384047.2015.1030555  0.308
2014 Allen JE, Saroya BS, Kunkel M, Dicker DT, Das A, Peters KL, Joudeh J, Zhu J, El-Deiry WS. Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs. Oncotarget. 5: 1753-60. PMID 24334302 DOI: 10.18632/Oncotarget.1524  0.306
2012 Talamo G, Dolloff NG, Sharma K, Zhu J, Malysz J. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents. Rare Tumors. 4: e39. PMID 23087795 DOI: 10.4081/Rt.2012.E39  0.321
Show low-probability matches.